Académique Documents
Professionnel Documents
Culture Documents
Documents
a DepartmentofPharmaceuticalTechnology,MedicalUniversityofBiaystok,Mickiewicza2c,Biaystok,Poland
b DepartmentofPharmaceuticalAnalysis,MedicalUniversityofBiaystok,Mickiewicza2d,Biaystok,Poland
Abstract
Highprofitabilityandsimplicityofdirectcompression,encouragespharmaceuticalindustrytocreateuniversalexcipients
toimprovetechnologyprocess.ProsolvSMCCsilicifiedmicrocrystallinecelluloseandStarch1500pregelatinized
starch,aretheexampleofmultifunctionalexcipients.Theaimofthepresentstudywastoevaluatethestabilityof
theophylline(API)inthemixtureswithexcipientswithvariousphysicochemicalproperties(ProsolvSMCC90,Prosolv
SMCCHD90,ProsolvSMCC50,Starch1500andmagnesiumstearate).Thestudypresentsresultsofthermal
analysisofthemixtureswiththeophyllinebeforeandafter6monthsstorageofthetabletsatvarioustemperaturesand
relativehumidityconditions(252C/405%RH,402C/755%RH).ItwasshownthathighconcentrationofStarch
1500(49%)affectsthestabilityofthetheophyllinetabletswithProsolvSMCC.ProsolvSMCChadnoeffectonAPI
stabilityasconfirmedbythedifferentialscanningcalorimetry(DSC).Changesinpeakplacementswereobservedjust
aftertablettingprocess,whichmightindicatethatcompressionacceleratedtheincompatibilitiesbetweentheophyllineand
Starch1500.TGAanalysisshowedlossintabletsmassequaltowatercontentinstarch.GCMSstudyestablishedno
chemicaldecompositionoftheophylline.WedemonstratedthathighcontentofStarch1500(49%)inthetabletmass,
affectsstabilityontabletscontainingtheophyllineandProsolvSMCC.2016,PolishPharmaceuticalSociety.Allrights
reserved.
AuthorKeywords
DrugexcipientcompatibilitystudiesDSCProsolvSMCCStarch1500TabletsTheophylline
References
Shangraw,R.F.
Compressedtabletsbydirectcompression
(1990)PharmaceuticalDosageForms:Tablets,2,p.195.
LeibermanH.A.,LachmanL.,SchwatzJ.B.,Eds.,MarcelDekker,NewYork
Gohel,M.C.,Jogani,P.D.
(2005)J.Pharm.Pharm.Sci.,8,p.76.
Shangraw,R.F.,Wallace,J.W.,Bowers,F.M.
(1987)Pharm.Technol.,11,p.136.
Bolhuis,G.K.,Chowhan,Z.T.
(1996)MaterialsforDirectCompression.PharmaceuticalPowderCompaction
Technology,7,p.419.
MarcelDekker,NewYork
Veen,B.,Bolhuis,G.K.,Wu,Y.S.,Zuurman,K.,Frijlink,H.W.
(2005)Eur.J.Pharm.Biopharm,59,p.133.
Reimerdes,D.
(1993)Manuf.Chem.,64(7),p.14.
Russell,R.
(2004)Pharm.Technol.,27,p.38.
https://remotelib.ui.ac.id:2164/citation/print.uri?origin=recordpage&sid=&src=s&stateKey=OFD_736148118&eid=2s2.084982699524&sort=&clickedLink=&vi 1/4
11/22/2016 ScopusPrintDocument
(2004)Pharm.Technol.,27,p.38.
Zeleznik,J.A.,Renak,J.
(2004)BusinessBriefing:Pharmagenerics,pp.14.
accessedon15April,2015
Reier,G.E.,Shangraw,R.F.
(1966)J.Pharm.Sci.,55,p.510.
Luukkonen,P.,Schaefer,T.,Hellen,L.,Juppo,A.M.,Yliruusi,J.
(1999)Int.J.Pharm.,188,p.181.
Allen,J.D.
(1996)Manuf.Chem.,67(12),p.19.
Steele,D.F.,Tobyn,M.,Edge,S.,Chen,A.,Staniforth,J.N.
(2004)Drug.Dev.Ind.Pharm.,30,p.103.
accessedon18april2015
Ansel,H.C.,Allen,L.V.,Propovich,N.G.
(2005)PharmaceuticalDosageFormsandDrugDeliverySystems,
8<sup>th</sup>edn.,LippincottWiliams&Wilkins,Baltimore
Trask,A.V.,Motherwell,W.D.,Jones,W.
(2006)IntJ.Pharm.,320,p.114.
Otsuka,Y.,Yamamoto,M.,Abe,H.,Otsuka,M.
(2013)ColloidsSurfacesBBiointerfaces,102,p.931.
Touil,A.,Peczalski,R.,Timoumi,S.,Zagrouba,F.
(2013)Int.J.Pharm.,2013.
Matsuo,K.,Matsuoka,M.
(2007)Cryst.GrowthDes.,7,p.411.
(2013)EuropeanPharmacopoeia,1,pp.297299.
8<sup>th</sup>edn.,CouncilofEurope,Strasbourg
(2009)UnitedStatesPharmacopoeia32,3,p.3710.
Rockvile,MD,USA
Verpoorte,R.,BaerheimSvendsen,A.
(1984)ChromatographyofAlkaloids:GasliquidChromatographyandHighperformance
LiquidChromatography,PartB,23B,p.200.
Elsevier,USA
Sun,C.,Zhou,D.,Grant,D.,Young,V.G.
(2002)ActaCryst.E,58,p.368.
Suzuki,E.,Shimomura,K.,Sekiguchi,K.
(1989)Chem.Pharm.Bull,37,p.493.
Matsuo,K.,Matsuoka,M.
(2007)J.Chem.Eng.Jpn,40,p.541.
https://remotelib.ui.ac.id:2164/citation/print.uri?origin=recordpage&sid=&src=s&stateKey=OFD_736148118&eid=2s2.084982699524&sort=&clickedLink=&vi 2/4
11/22/2016 ScopusPrintDocument
(2007)J.Chem.Eng.Jpn,40,p.541.
Otsuka,M.,Kaneniwa,N.,Kawakami,K.,Umezawa,O.
(1990)J.Pharm.Pharmacol.,42,p.606.
Zhu,H.,Yuen,C.,Grant,D.J.
(1996)Int.J.Pharm.,135,p.151.
Ticehurst,M.D.,Storey,R.A.,Watt,C.
(2002)Int.J.Pharm.,247,p.1.
Legendre,B.,Randzo,S.L.
(2007)Int.J.Pharm.,343,p.41.
Brittain,H.G.,Grant,D.J.
(2001)Adv.DrugDeliv.Rev.,4,p.3.
Seton,L.,Khamar,D.,Bradshav,I.J.,Hutcheon,G.A.
(2010)CrystalGrowthDes.,10,p.3879.
Debnath,S.,Predecki,P.,Suryanarayanan,R.
(2004)Pharm.Res.,21,p.149.
Debnath,S.,Suryanarayanan,R.
(2004)AAPSPharm.Sci.Tech.,5,p.E8.
Saska,Z.,Dredan,J.,Balogh,E.,Luhn,O.,Shafir,G.,Antal,I.
(2010)PowderTechnol.,201,p.123.
Mura,P.,Faucci,M.T.,Manderioli,A.,Bramanti,G.,Ceccarelli,L.
(1998)J.Pharm.Biomed.Anal,18,p.151.
Crowley,P.J.
(1999)Pharm.Sci.Technol.Today,2,p.237.
MazurekWadokowska,E.,CzajkowskaKonik,A.,Winnicka,K.,Czyzewska,U.,Miltyk,
W.
(2013)ActaPol.Pharm.DrugRes.,70,p.787.
Sandler,N.,Reiche,K.,Heinamaky,Yliruusi,J.
(2010)Pharmaceutics,2,p.275.
Callahan,J.C.,Cleary,G.W.,Elefant,M.,Kaplan,G.,Kensler,T.,Nash,R.A.
(1982)DrugDev.Ind.Pharm.,8,p.355.
Schulze,D.
(2006)StorageofPowdersandBulkSolidsinSilos,
DietmarSchulze.com(accessedon12April,2015)
CorrespondenceAddress
MazurekWadolkowskaE.DepartmentofPharmaceuticalTechnology,MedicalUniversityofBiaystok,Mickiewicza2c,
Polandemail:edyta.wadolkowska@umb.edu.pl
Publisher:PolishPharmaceuticalSociety
ISSN:00016837
CODEN:APPHA
LanguageofOriginalDocument:English
AbbreviatedSourceTitle:ActaPol.Pharm.DrugRes.
DocumentType:Article
https://remotelib.ui.ac.id:2164/citation/print.uri?origin=recordpage&sid=&src=s&stateKey=OFD_736148118&eid=2s2.084982699524&sort=&clickedLink=&vi 3/4
11/22/2016 ScopusPrintDocument
DocumentType:Article
Source:Scopus
Copyright2016ElsevierB.V.Allrightsreserved.Scopusisaregistered
trademarkofElsevierB.V.
https://remotelib.ui.ac.id:2164/citation/print.uri?origin=recordpage&sid=&src=s&stateKey=OFD_736148118&eid=2s2.084982699524&sort=&clickedLink=&vi 4/4